Home›Companies›Biotech & Pharma›ReAlta Life Sciences

ReAlta Life Sciences, Inc.

Updated Oct 27, 2026·Latest SEC filing May 21, 2025·Suggest an edit

About ReAlta Life Sciences

ReAlta Life Sciences is a private company based in Norfolk, Virginia. It has reported $94,277,445 raised in seven offerings on Form D since September 2018.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 7, 2023May 21, 2025$29,929,943of $30.0M target149$200KEquity, Shares of Series A-5 Preferred Stock and underlying shares of common stock issuable upon conversion thereofRule 506(b)Form D ↗
Dec 18, 2024May 21, 2025$25,000,141fully sold109$229KEquity, Shares of Series A-6 Preferred Stock and underlying shares of common stock issuable upon conversion thereofRule 506(b)Form D ↗
Feb 22, 2023May 21, 2025$11,999,998fully sold85$141KEquity, Shares of Series A-4 Preferred Stock and underlying shares of common stock issuable upon conversion thereofRule 506(b)Form D ↗
Dec 18, 2020Sep 13, 2023$22,500,017fully sold92$244KEquity, Shares of Series A-3 Preferred Stock and underlying shares of common stock issuable upon conversion thereofRule 506(b)Form D ↗
Not yetFeb 19, 2020$0of $2.0M target0—EquityRule 506(b)Form D ↗
Not yetOct 28, 2019$0of $12.0M target0—EquityRule 506(b)Form D ↗
Sep 10, 2018Sep 12, 2018$4,847,346of $12.0M target1$4.8MEquityRule 506(b)Form D ↗
Total, seven offerings$94,277,445

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ReAlta Life Sciences's Form D filed May 21, 2025.

LG
DM
David Marek
Executive officer and director
LW
AM
KC
Kenji Cunnion
Executive officer
JR
John Rickman
Chief Financial Officer
FG
Frank Gadams
Director
PM
Paolo Martini
Executive officer
ER
Emma Reeve
Director
MA
Mert Aktar
Director
CS
Christi Shaw
Director
NK
Neel Krishna
Executive officer

Earlier filings also listed Ulrich Thienel (chief executive officer and director, last listed Sep 2023), Kathryn Abshire (executive officer, last listed Sep 2023), Jonathan Zalevsky (director, last listed Sep 2023), Deborah Geraghty (director, last listed Sep 2023), Christine Neikirk (director, last listed Sep 2023), Barry Strasnick (director, last listed Sep 2023), Azmi Nabulsi (director, last listed Sep 2023) and Thomas McCarter (vice president, last listed Feb 2020).

Sources

  1. SECReAlta Life Sciences, Inc. filing history